Education
About Us
Working with TipRanks
Follow Us
Ind-Swift Ltd. (IN:INDSWFTLTD)
:INDSWFTLTD
INDSWFTLTD Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ind-Swift Ltd. News
INDSWFTLTD FAQ
What was Ind-Swift Ltd.’s price range in the past 12 months?
Currently, no data Available
What is Ind-Swift Ltd.’s market cap?
Currently, no data Available
When is Ind-Swift Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ind-Swift Ltd.’s earnings last quarter?
Currently, no data Available
Is Ind-Swift Ltd. overvalued?
According to Wall Street analysts Ind-Swift Ltd.’s price is currently Undervalued.
Does Ind-Swift Ltd. pay dividends?
Ind-Swift Ltd. does not currently pay dividends.
What is Ind-Swift Ltd.’s EPS estimate?
Ind-Swift Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ind-Swift Ltd. have?
Currently, no data Available
What happened to Ind-Swift Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ind-Swift Ltd.?
Currently, no hedge funds are holding shares in IN:INDSWFTLTD
Company Description
Ind-Swift Ltd.
Ind-Swift Ltd. is a pharmaceutical company engaged in the development, manufacture, and marketing of a wide range of pharmaceutical products. The company operates in the healthcare sector, with a focus on producing generic and proprietary drug formulations. Its product portfolio includes tablets, capsules, injectables, and syrups, catering to various therapeutic segments such as cardiology, neurology, and anti-infectives.